Steven Cohen's INBX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 26,011 shares of Inhibrx Biosciences, Inc. (INBX) worth $2.46 M, representing 0.00% of the portfolio. First purchased in 2022-Q2, this short-term holding has been held for 7 quarters.
Based on 13F filings, Steven Cohen has maintained this position in INBX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2022, adding 295,400 shares. Largest reduction occurred in Q1 2023, reducing 513,381 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Inhibrx Biosciences (INBX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Inhibrx Biosciences (INBX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +26,011 | New Buy | 26,011 | $94.75 |
| Q3 2023 | -319,500 | Sold Out | 0 | $0.00 |
| Q2 2023 | +80,381 | Add 33.62% | 319,500 | $25.96 |
| Q1 2023 | -513,381 | Reduce 68.22% | 239,119 | $18.87 |
| Q4 2022 | +295,400 | Add 64.62% | 752,500 | $24.64 |
| Q3 2022 | -242,000 | Reduce 34.62% | 457,100 | $17.95 |
| Q2 2022 | +699,100 | New Buy | 699,100 | $11.35 |
Steven Cohen's Inhibrx Biosciences Investment FAQs
Steven Cohen first purchased Inhibrx Biosciences, Inc. (INBX) in Q2 2022, acquiring 699,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Inhibrx Biosciences, Inc. (INBX) for 7 quarters since Q2 2022.
Steven Cohen's largest addition to Inhibrx Biosciences, Inc. (INBX) was in Q2 2022, adding 699,100 shares worth $7.94 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 26,011 shares of Inhibrx Biosciences, Inc. (INBX), valued at approximately $2.46 M.
As of the Q2 2026 filing, Inhibrx Biosciences, Inc. (INBX) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Inhibrx Biosciences, Inc. (INBX) was 752,500 shares, as reported at the end of Q4 2022.